P
2080
Our goal is to make desensitization treatment more effective, safer, and easier for the patient. Desentum's CEO, Pekka Mattila, reveals that with the funds raised now, the company is able to fully advance its three flagship projects related to birch, peanut, and cat allergies. #allergiat #rokotteet #terveys (translated)
Voiko allergian siedätyshoito kutistua vuosista kuukausiin? Suomalaisyhtiö sai jättirahoituksen
www.mtvuutiset.fi